| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| K J Weis. Optimal management of anxiety in older patients. Drugs & aging. vol 9. issue 3. 1997-01-21. PMID:8877313. |
the selective serotonin reuptake inhibitors appear to be better suited to treating syndromes such as panic and obsessive-compulsive disorder, whereas nefazodone would be a better choice for generalised anxiety complicated by depression. |
1997-01-21 |
2023-08-12 |
Not clear |
| J R Brubacher, R S Hoffman, M J Luri. Serotonin syndrome from venlafaxine-tranylcypromine interaction. Veterinary and human toxicology. vol 38. issue 5. 1997-01-21. PMID:8888541. |
we report a venlafaxine-maoi interaction that resulted in the serotonin syndrome in a 23-y-old male who was taking tranylcypromine for depression. |
1997-01-21 |
2023-08-12 |
Not clear |
| D F Papolos, Y M Yu, E Rosenbaum, H M Lachma. Modulation of learned helplessness by 5-hydroxytryptamine2A receptor antisense oligodeoxynucleotides. Psychiatry research. vol 63. issue 2-3. 1997-01-16. PMID:8878316. |
to understand the significance of neuronal responses in depression and lh that are mediated by serotonin (5-hydroxytryptamine, 5ht) receptors, we used intracerebroventricular injections to introduce a unique antisense oligonucleotide (aso) to the 5ht2a receptor and determined its effect on lh behavior in sprague-dawley rats as determined by an escape-avoidance strategy. |
1997-01-16 |
2023-08-12 |
rat |
| D F Papolos, Y M Yu, E Rosenbaum, H M Lachma. Modulation of learned helplessness by 5-hydroxytryptamine2A receptor antisense oligodeoxynucleotides. Psychiatry research. vol 63. issue 2-3. 1997-01-16. PMID:8878316. |
these data support the view that central 5ht, mediated by the 5ht2a receptor, participates in regulating behaviors that are affected by inescapable stress, and that the induction of behavioral depression may be specifically regulated via serotonergic pathways that terminate in this hippocampal subfield. |
1997-01-16 |
2023-08-12 |
rat |
| G E Ruof. Depression in the patient with chronic pain. The Journal of family practice. vol 43. issue 6 Suppl. 1997-01-15. PMID:8969710. |
regardless of their etiology, evidence exists to suggest that depression and chronic pain share common biologic pathways, namely, the serotonergic (5-ht) and noradrenergic systems. |
1997-01-15 |
2023-08-12 |
Not clear |
| G E Ruof. Depression in the patient with chronic pain. The Journal of family practice. vol 43. issue 6 Suppl. 1997-01-15. PMID:8969710. |
the newer antidepressants, including the selective serotonin reuptake inhibitors venlafaxine and nefazodone, are therapeutic options for the treatment of depression in the patient with chronic pain. |
1997-01-15 |
2023-08-12 |
Not clear |
| P J Perr. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. Journal of affective disorders. vol 39. issue 1. 1997-01-14. PMID:8835647. |
pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. |
1997-01-14 |
2023-08-12 |
Not clear |
| P J Perr. Pharmacotherapy for major depression with melancholic features: relative efficacy of tricyclic versus selective serotonin reuptake inhibitor antidepressants. Journal of affective disorders. vol 39. issue 1. 1997-01-14. PMID:8835647. |
the effectiveness of tricyclic antidepressants (tcas) and selective serotonin reuptake inhibitors (ssris) were contrasted in endogenous/melancholic depression. |
1997-01-14 |
2023-08-12 |
Not clear |
| D Mück-Seler, M Jakovljević, N Piva. Platelet 5-HT concentrations and suicidal behaviour in recurrent major depression. Journal of affective disorders. vol 39. issue 1. 1997-01-14. PMID:8835656. |
platelet 5-ht concentrations and suicidal behaviour in recurrent major depression. |
1997-01-14 |
2023-08-12 |
Not clear |
| J Tiihonen, M Kuoppamäki, K Någren, J Bergman, E Eronen, E Syvälahti, J Hietal. Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography. Psychopharmacology. vol 126. issue 4. 1997-01-10. PMID:8878342. |
citalopram is a selective serotonin reuptake inhibitor widely used in the treatment of depression (20-40 mg/day). |
1997-01-10 |
2023-08-12 |
human |
| A Suwalska, J Rybakowsk. [Biological mechanisms of drug-resistant depression]. Psychiatria polska. vol 30. issue 5. 1997-01-08. PMID:8984513. |
efficacy of therapeutic strategies enhancing serotonergic function such as potentiation of tricyclic antidepressants with lithium or fluoxetine as well as effectiveness of selective serotonin reuptake inhibitors in drug-resistant depression may support this hypothesis. |
1997-01-08 |
2023-08-12 |
Not clear |
| L J Albers, C Reist, D Helmeste, R Vu, S W Tan. Paroxetine shifts imipramine metabolism. Psychiatry research. vol 59. issue 3. 1997-01-02. PMID:8930024. |
the combination of selective serotonin reuptake inhibitors with tricyclic antidepressants has proven useful in treatment-resistant depression but has the potential for adverse drug-drug interactions. |
1997-01-02 |
2023-08-12 |
Not clear |
| G R Heninger, P L Delgado, D S Charne. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans. Pharmacopsychiatry. vol 29. issue 1. 1996-12-23. PMID:8852528. |
in order to test this hypothesis and more fully characterize the role of serotonin and catecholamines in the pathophysiology of depression and the mechanism of action of antidepressant treatments, our research group has conducted a series of studies evaluating monoamine depletion induced brief clinical relapse following different types of antidepressant treatment of depressed patients. |
1996-12-23 |
2023-08-12 |
Not clear |
| M E Bradley, E F Foote, E N Lee, L Merkl. Sertraline-associated syndrome of inappropriate antidiuretic hormone: case report and review of the literature. Pharmacotherapy. vol 16. issue 4. 1996-12-19. PMID:8840376. |
selective serotonin reuptake inhibitors have gained widespread use in the treatment of depression. |
1996-12-19 |
2023-08-12 |
Not clear |
| R Davis, M I Wild. Sertraline. A pharmacoeconomic evaluation of its use in depression. PharmacoEconomics. vol 10. issue 4. 1996-12-13. PMID:10184609. |
because of their higher acquisition costs relative to tricyclic antidepressants (tcas), there has been much debate about whether the use of sertraline or other selective serotonin reuptake inhibitors (ssris) for first-line treatment of depression can be justified. |
1996-12-13 |
2023-08-12 |
Not clear |
| E Richelso. Synaptic effects of antidepressants. Journal of clinical psychopharmacology. vol 16. issue 3 Suppl 2. 1996-12-06. PMID:8784643. |
catecholamines, especially norepinephrine (ne) and serotonin (5-hydroxytryptamine [5-ht]), have been implicated in the pathophysiology of depression. |
1996-12-06 |
2023-08-12 |
Not clear |
| M E Thas. Antidepressant options: venlafaxine in perspective. Journal of clinical psychopharmacology. vol 16. issue 3 Suppl 2. 1996-12-06. PMID:8784644. |
depression is often related to disturbances of norepinephrine and serotonin neurochemical systems within the brain that affect functional neurobehavioral systems. |
1996-12-06 |
2023-08-12 |
Not clear |
| T R Allan, L Goldstei. Selective serotonin reuptake inhibitors in the treatment of mood disorders in primary care: depression and premenstrual syndrome. Connecticut medicine. vol 60. issue 4. 1996-12-03. PMID:8776125. |
selective serotonin reuptake inhibitors in the treatment of mood disorders in primary care: depression and premenstrual syndrome. |
1996-12-03 |
2023-08-12 |
Not clear |
| A J Cleare, A McGregor, S M Chambers, S Dawling, V O'Kean. Thyroxine replacement increases central 5-hydroxytryptamine activity and reduces depressive symptoms in hypothyroidism. Neuroendocrinology. vol 64. issue 1. 1996-12-03. PMID:8811668. |
hypothyroidism is associated with both reduced central 5-ht function and an increased incidence of depression. |
1996-12-03 |
2023-08-12 |
Not clear |
| R D MAGUS, F W KRAUSE, B E RIEDE. DISSOCIATION OF RESERPINE-INDUCED DEPRESSION OF SPONTANEOUS MOTOR ACTIVITY AND RELEASE OF BRAIN SEROTONIN IN RATS. Biochemical pharmacology. vol 13. 1996-12-01. PMID:14186845. |
dissociation of reserpine-induced depression of spontaneous motor activity and release of brain serotonin in rats. |
1996-12-01 |
2023-08-12 |
rat |